Albert David Share Price Live
Live Albert David Share Price Chart
Albert David Performance
Days Range
| Previous Close | ₹801.25 |
|---|---|
| Open | ₹802 |
| Volume | 3,421 |
| Day's Range | ₹785.00 - ₹802.00 |
|---|---|
| 52W Range | ₹762.60 - ₹1,540.00 |
| Market Cap | ₹462.65 Cr |
Albert David Fundamentals
| ROCE(TTM) | -3.33 |
|---|---|
| P/E Ratio (TTM) | -30.68 |
| P/B Ratio | 1.17 |
| Industry P/E | 40.20 |
| Debt to Equity | 0.11 |
| ROE | -3.83 |
| EPS (TTM) | 0 |
| Dividend Yield | 0.62 |
| Book Value | 689.84 |
| Face Value | 10 |
| ROCE(TTM) | -3.33 |
|---|---|
| P/E Ratio (TTM) | -30.68 |
| P/B Ratio | 1.17 |
| Industry P/E | 40.20 |
| Debt to Equity | 0.11 |
| ROE | -3.83 |
|---|---|
| EPS (TTM) | 0 |
| Dividend Yield | 0.62 |
| Book Value | 689.84 |
| Face Value | 10 |
Albert David Financials
| Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | |
|---|---|---|---|---|
| Net Sales | 83.08 | 74.89 | 70.57 | 87.24 |
| Expenses | 84.11 | 81.46 | 83.61 | 86.93 |
| Profit before tax | -10.16 | -11.81 | 8.44 | -2.58 |
| Operating Profit | -9.39 | -10.33 | 7.94 | -3.30 |
| Net Profit | -9.39 | -10.33 | 7.94 | -3.30 |
| ESP in Rs | -16.45 | -18.10 | 13.91 | -5.79 |
Albert David Shareholding Pattern
| Held by | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|---|---|---|---|---|
| Promoters | 62.13% | 62.13% | 62.24% | 62.24% | 62.24% |
| Flls | 0.88% | 0.86% | 1.01% | 0.84% | 0.6% |
| Dlls | 1.64% | 1.64% | 1.65% | 1.66% | 1.66% |
| Public | 35.35% | 35.37% | 35.11% | 35.26% | 35.5% |
About Albert David
Incorporated in 1938 at Calcutta, Albert David (ADL) is headed by Chairman A K Kothari. Its units at Calcutta, Ghaziabad and Raisin manufacture pharmaceutical formulations, including amino acid infusions. The company also manufactures disposable syringes and needles and a wide range of bulk drugs. It is recognised as a large IV fluid manufacturer, both in glass and polyethylene containers.
ADL has entered into a technical collaboration with Morishita Pharmaceuticals, Japan, a subsidiary of Ajinomoto -- the world leader in amino acids -- to manufacture amino acid infusions, for which it came out with a rights issue in Aug.'87. It has also set up a new unit in Kalyani, West Bengal, to manufacture bulk drugs, which went on stream in 1990. Another rights issue in Mar.'90 augmented the long-term working capital.
ADL has entered into technical collaboration with Pharma Plan, Germany, to supply machinery to manufacture 30 mln disposable syringes and 70 mln needles at Mandideep near Bhopal. ADL came up with a Rs 4.68-cr right issue to part finance the expansion of its capacity of IV fluids in plastic bottles (FFS technology) at Ghaziabad.
During 1998-99, the company has developed some new products viz. Siozole Capsules and Ferrochelate-Z-Capsules with Iron & Zinc and folic acid in sustained released formulation. In 2002-03 the company has launched new products-INTECAR,NIMERIL-T,EVICT,ALROF-50. It is also planning to launch new products such as SIOOXY,ALAMIN FEZ,PANSURE.
Parent Organisation
Indian Private
Managing Director
A K Kothari
Founded
1938
NSE Symbol
ALBERTDAVD
Top Mutual Funds Invested in Albert David Share
Top Mutual Funds Invested in Albert David Share
| FUND NAME | AUM(%) |
|---|---|
Peer Comparison
Peer Comparison
| Stocks | LTP (₹) | Market Cap (cr) | 52 Week Low-High (₹) |
|---|---|---|---|
| Sun Pharmaceutical Industries Ltd | 1,779.5 2.10 (0.12%) | ₹4,26,565.77 | 1,548.0 - 1,910.0![]() |
| Divis Laboratories Ltd | 6,379.0 -83.50 (-1.29%) | ₹1,71,593.58 | 4,955.0 - 7,071.5![]() |
| Torrent Pharmaceuticals Ltd | 3,681.6 -39.80 (-1.07%) | ₹1,25,819.90 | 2,886.45 - 3,882.2![]() |
| Cipla Ltd | 1,512.1 -17.10 (-1.12%) | ₹1,23,504.18 | 1,335.0 - 1,673.0![]() |
| Dr Reddys Laboratories Ltd | 1,242.5 -6.10 (-0.49%) | ₹1,04,131.51 | 1,020.0 - 1,405.9![]() |
| Zydus Lifesciences Ltd | 924.7 -3.30 (-0.36%) | ₹93,338.26 | 795.0 - 1,059.05![]() |
Popular stocks
Albert David Limited FAQs
What is the share price of Albert David Limited (ALBERTDAVD) shares?
Albert David Limited (ALBERTDAVD) share price as of November 21, 2025, on NSE is Rs 787 (NSE) and Rs 787 (BSE) on BSE.
Can I buy Albert David Limited (ALBERTDAVD) from Angel One?
Yes, You can buy Albert David Limited (ALBERTDAVD) shares by opening a Demat account with Angel One.
How do I buy Albert David Limited (ALBERTDAVD) from Angel One?
Albert David Limited (ALBERTDAVD) share can be bought through the following modes:
1. Direct investment: You can buy Albert David Limited (ALBERTDAVD) shares by opening a Demat account with Angel One.
2. Indirect investment: The indirect method involves investing through ETFs and Mutual Funds that offer exposure to Albert David Limited (ALBERTDAVD) shares.
1. Direct investment: You can buy Albert David Limited (ALBERTDAVD) shares by opening a Demat account with Angel One.
2. Indirect investment: The indirect method involves investing through ETFs and Mutual Funds that offer exposure to Albert David Limited (ALBERTDAVD) shares.
What is the main business of Albert David?
Albert David Ltd is involved in the production and distribution of pharmaceutical formulations, infusion solutions, herbal dosage forms, and bulk drugs, both for domestic sales and export purposes.
Who are the promoters of Albert David?
Kothari Investment And Industries Private Limited, Anand Vardhan Kothari, and M D Kothari And Company Limited are the major promoters of Albert David.
What are the Subsidiaries that comes under Albert David?
There are no subsidiaries that come under Albert David.




